共 50 条
Completely reversed acute rejection is not a significant risk factor for the development of chronic rejection in renal allograft recipients
被引:35
|作者:
Madden, RL
[1
]
Mulhern, JG
[1
]
Benedetto, BJ
[1
]
O'Shea, MH
[1
]
Germain, MJ
[1
]
Braden, GL
[1
]
O'Shaughnessy, J
[1
]
Lipkowitz, GS
[1
]
机构:
[1] Tufts Univ, Sch Med, Baystate Med Ctr, Dept Surg,Div Transplantat, Springfield, MA 01199 USA
关键词:
renal transplantation;
acute rejection;
chronic rejection;
D O I:
10.1111/j.1432-2277.2000.tb01008.x
中图分类号:
R61 [外科手术学];
学科分类号:
摘要:
Although acute rejection (AR) has been shown to correlate with decreased long-term renal allograft survival, we have noted AR in recipients who subsequently had stable function for more than 5 years. We reviewed 109 renal graft recipients with a minimum of 1 year graft survival and follow-up of 5-8 years. Post-transplant sodium iothalamate clearances (IoCl) measured at 3 months and yearly thereafter were used to separate recipients into 2 groups. Ln 61 patients (stable group), there was no significant decrease ( > 20 % reduction in IoCl over 2 consecutive years) in IoCl. Forty-eight patients had significant declines in IoCl (decline group). Groups were compared for incidence, severity, timing, and completeness of reversal of AR. Rejection was considered completely reversed if the post-AR serum creatinine (Scr) returned to or below the pre-AR nadir Scr after antirejection therapy. The incidence of AR was not significantly different between groups (47 % vs 52 %). A trend toward a lower mean number of AR episodes per patient was noted in the stable group (0.69 vs 1.04, P = 0.096), but the timing of AR was not different. Steroid-resistant AR occurred in approximately 25 % of both groups. A striking difference was seen in complete reversal of AR, with the stable group having 100 % (42/42 episodes of AR in 29 patients) complete reversal whereas only 32 % (8/25) of the patients in the decline group had complete reversal (P < < 0.001). Of 8 declining patients with complete reversal, graft loss was due to chronic rejection (CR) in only 3. Seventeen declining patients had incomplete reversal of AR, and 82 % (14/17) lost their grafts to CR. Overall, only 8 % (3/37) of the recipients with complete reversal of AR developed CR. No patients with incompletely reversed BR had stable long-term function as measured by IoCl. AR is not invariably deleterious to longterm renal graft function if each episode of AR can be completely reversed.
引用
收藏
页码:344 / 350
页数:7
相关论文